Interferon-alpha as first-line therapy for treatment of multicentric Castleman's disease.
Andrès
E
E
Department of Internal Medicine, University Hospital Hautepierre, Strasbourg, France. emmanuel.andres@chru-strasbourg.fr
Maloisel
F
F
D005871:Castleman Disease / Q000188:drug therapy* / Q000276:immunology; D015536:Down-Regulation; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D016898:Interferon-alpha / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019947:Receptors, Interleukin-6 / Q000187:drug effects
D007155:Immunologic Factors; D016898:Interferon-alpha; D019947:Receptors, Interleukin-6